Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Total Non-Current Liabilities (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $17.2 million as the latest value for Q4 2019.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A to $17.2 million in Q4 2019 year-over-year; TTM through Dec 2019 was $17.2 million, a N/A change, with the full-year FY2019 number at $17.2 million, changed N/A from a year prior.
  • Total Non-Current Liabilities was $17.2 million for Q4 2019 at Forte Biosciences, down from $50.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $50.9 million in Q3 2019 to a low of $17.2 million in Q4 2019.